New York Times Top Stories
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.